Brad H. Rovin
Active 1989–2025
- 182
- Papers
- 33,266
- Citations
- 89
- h-index
- 174
- i10-index
Citations
Citation sources
Countries
Institutions
- Harvard University0.8%
- Johns Hopkins University0.7%
- Inserm0.7%
- Brigham and Women's Hospital0.5%
- Mayo Clinic0.4%
- University of Washington0.4%
- Other96.5%
Fields
- Medicine72%
- Biochemistry, Genetics and Molecular Biology15.7%
- Immunology and Microbiology7.6%
- Neuroscience0.8%
- Agricultural and Biological Sciences0.6%
- Engineering0.5%
- Other2.8%
Topics
- Renal Diseases and Glomerulopathies8%
- Systemic Lupus Erythematosus Research7.1%
- Chronic Kidney Disease and Diabetes5.7%
- Vasculitis and related conditions3%
- T-cell and B-cell Immunology2%
- Dialysis and Renal Disease Management1.8%
- Other72.4%
Coauthors
- Jonathan Barratt29
- Jürgen Floege26
- Lee A. Hebert24
- Samir V. Parikh23
- Ana Malvar21
- Tibor Nádasdy19
- Haikady N. Nagaraja18
- Anjali A. Satoskar17
- Fernando C. Fervenza15
- Richard Lafayette15
- Hernán Trimarchi14
- Jai Radhakrishnan13
- Isabelle Ayoub12
- Sergey V. Brodsky12
- Juan M. Mejía‐Vilet11
- Richard Furie11
- Gyongyi Nadasdy10
- Heather N. Reich10
- Hong Zhang10
- Vladimı́r Tesař10
- C. Yung Yu9
- H. Terence Cook9
- Huijuan Song9
- James A. Tumlin9
All papers
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Authors: Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Carla Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan‐Stephan Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney Tang, Vladimı́r Tesař, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege - Kidney International 2021 cited by 2,416
- An atlas of healthy and injured cell states and niches in the human kidney
Authors: Blue B. Lake, Rajasree Menon, Seth Winfree, Qiwen Hu, Ricardo Melo Ferreira, Kian Kalhor, Daria Barwinska, Edgar A. Otto, Michael J. Ferkowicz, Dinh Diep, Nongluk Plongthongkum, Amanda Knoten, Sarah Urata, Laura H. Mariani, Abhijit S. Naik, Sean Eddy, Bo Zhang, Yan Wu, Diane Salamon, James C. Williams, Xin Wang, Karol S. Balderrama, Paul Hoover, Evan Murray, Jamie L. Marshall, Teia Noel, Anitha Vijayan, Austin Hartman, Fei Chen, Sushrut S. Waikar, Sylvia E. Rosas, F. Perry Wilson, Paul M. Palevsky, Krzysztof Kiryluk, John R. Sedor, Robert D. Toto, Chirag R. Parikh, Eric H. Kim, Rahul Satija, Anna Greka, Evan Z. Macosko, Peter V. Kharchenko, Joseph P. Gaut, Jeffrey B. Hodgin, Richard A. Knight, Stewart H. Lecker, Isaac E. Stillman, Afolarin Amodu, Titlayo Ilori, Shana Maikhor, Insa M. Schmidt, Gearoid M. McMahon, Astrid Weins, Nir Hacohen, Lakeshia Bush, Agustin Gonzalez‐Vicente, Jonathan J. Taliercio, John O’Toole, Emilio D. Poggio, Leslie Cooperman, Stacey E. Jolly, Leal Herlitz, Jane Nguyen, Ellen L. Palmer, Dianna Sendrey, Kassandra Spates-Harden, Paul S. Appelbaum, Jonathan Barasch, Andrew S. Bomback, Vivette D. D’Agati, Karla Mehl, Pietro A. Canetta, Ning Shang, Olivia Balderes, Satoru Kudose, Laura Barisoni, Theodore Alexandrov, Ying‐Hua Cheng, Kenneth W. Dunn, Katherine J. Kelly, Timothy A. Sutton, Yumeng Wen, Celia P. Corona-Villalobos, Steven Menez, Avi Z. Rosenberg, Mohammed Atta, Camille Johansen, Jennifer K. Sun, Neil Roy, Mark Williams, Evren U. Azeloglu, Cijang He, Ravi Iyengar, Jens Hansen, Yuguang Xiong, Brad H. Rovin, Samir V. Parikh, Sethu M. Madhavan, Christopher Anderton, Ljiljana Paša‐Tolić and 70 more - Nature 2023 cited by 693
- Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Authors: Lee A. Hebert, Samir M. Parikh, Jason Prosek, Tibor Nádasdy, Brad H. Rovin - American Journal of Nephrology 2013 cited by 4,380
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Authors: Richard Furie, Brad H. Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B. Santiago, Amit Saxena, Yulia Green, Beulah Ji, C. Kleoudis, Susan W. Burriss, Carly Barnett, David A. Roth - New England Journal of Medicine 2020 cited by 973
- B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
Authors: Richard Furie, Gustavo Aroca, Matthew D. Cascino, Jay Garg, Brad H. Rovin, Analía Álvarez, Hilda Fragoso-Loyo, Elizabeth Zuta-Santillan, Thomas H. Schindler, Paul Brunetta, Cary M. Looney, Imran Hassan, Ana Malvar - Annals of the Rheumatic Diseases 2022 cited by 438
- Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Authors: Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Carla Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan‐Stephan Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney Tang, Vladimı́r Tesař, Marina Vivarelli, Jack F.M. Wetzels, Lyubov Lytvyn, Jonathan C. Craig, David J. Tunnicliffe, Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Jürgen Floege - Kidney International 2021 cited by 791
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
Authors: Brad H. Rovin, Richard Furie, Kevin Latinis, R. John Looney, Fernando C. Fervenza, Jorge Sánchez‐Guerrero, Romeo Maciuca, David Zhang, Jay Garg, Paul Brunetta, Gerald B. Appel, LUNAR Investigator Group - Arthritis & Rheumatism 2012 cited by 1,437
- Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Authors: Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler, Cristina Arriens, Dawn J. Caster, Juanita Romero‐Díaz, Keisha L. Gibson, Joshua M. Kaplan, Laura Lisk, Sandra Navarra, Samir V. Parikh, Simrat Randhawa, Neil Solomons, Robert B. Huizinga - The Lancet 2021 cited by 593
- Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Authors: Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, Charles E. Alpers, Stewart Bieler, Dong-Wan Chae, Ulysses Diva, Jürgen Floege, Loreto Gesualdo, Jula K. Inrig, Donald E. Kohan, Radko Komers, Laura Kooienga, Richard Lafayette, Bart Maes, Robert Małecki, Alex Mercer, Irene L. Noronha, Se Won Oh, Chen Au Peh, Manuel Praga, Priscila Preciado, Jai Radhakrishnan, Michelle N. Rheault, William E. Rote, Sydney Tang, Vladimı́r Tesař, Howard Trachtman, Hernán Trimarchi, James A. Tumlin, Muh Geot Wong, Vlado Perkovic, Isabella Abbasciano, Catarina Abrantes, Simone Accarino, Sharon G. Adler, Annika Adoberg, Rouzbeh Afsari, Syeda B. Ahmad, Jafar Ahmed, Wooin Ahn, Bamidele Ajayi, Dariusz Aksamit, Saif Al‐Chalabi, É. Alamartine, Bassam Alchi, Mohammad Ali, Roberta Aliotta, Salem Almaani, Catarina Almeida, Edgar Almeida, Francisco de la Prada Álvarez, Patrícia Marques‐Alves, Francesca Annese, Gerald B. Appel, Gerald Appel, Maria Arena, Marta Calvo Arevalo, Dariush Arfaania, Carlos Arias, Emma Calatayud Aristoy, Eglė Ašakienė, Sarah Ashley, Ali Assefi, Alba Atenza, Asta Auerbach, Hanna Augustyniak‐Bartosik, Hanna Augustyniak-Bartosik, Jonathan Ayling-Smith, Isabelle Ayoub, Isabelle Ayoub, Rocco Baccaro, Asha Bailey, Bruce Baker, Saravanan Balamuthusamy, José Ballarín, Rui Barata, Jerko Barbić, Dunja Barisic, Jonathan Barratt, José C. Barreto, Clara Barrios, Mirco Belingheri, Anna Benesova, Ana Ávila Bernabéu, Wanja Bernhardt, Shamik Bhadra, Luigi Biancone, Anne Blanchard, Elena Boaglio, Davide Bolignano, Andrew S. Bomback, Gustavo Andres Useche Bonilla, M Bordoli, Bhadran Bose, Neil Boudville, Donald Brandon, Donald Brandon, Karen Brown, C Broyet and 634 more - The Lancet 2023 cited by 267
- Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
Authors: Richard Lafayette, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Jonathan Barratt - The Lancet 2023 cited by 289
- KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Authors: Brad H. Rovin, Isabelle Ayoub, Tak Mao Chan, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Jürgen Floege - Kidney International 2024 cited by 418
- Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal
Authors: Doua F. Azzouz, Aidana Omarbekova, Adriana Heguy, Dominik Schwudke, Nicolas Gisch, Brad H. Rovin, Roberto Caricchio, Jill P. Buyon, Alexander V. Alekseyenko, Gregg J. Silverman - Annals of the Rheumatic Diseases 2019 cited by 433
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Authors: Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour, Brad H. Rovin, Richard Lafayette, Nabeel Aslam, Jonathan Ashley Jefferson, Patrick E. Gipson, Dana V. Rizk, John R. Sedor, James F. Simon, Ellen T. McCarthy, Paul Brenchley, Sanjeev Sethi, Carmen Ávila-Casado, Heather Beanlands, John C. Lieske, David Philibert, Tingting Li, Leslie F. Thomas, Dolly F. Green, Luis A. Juncos, Lada Beara‐Lasić, Samuel S. Blumenthal, Amy N. Sussman, Stephen B. Erickson, Michelle Hladunewich, Pietro A. Canetta, Lee A. Hebert, Nelson Leung, Jay Radhakrishnan, Heather N. Reich, Samir V. Parikh, Debbie S. Gipson, Dominic K. Lee, Bruno R. da Costa, Peter Jüni, Daniel Cattran - New England Journal of Medicine 2019 cited by 600
- Update on Lupus Nephritis: Core Curriculum 2020
Authors: Samir V. Parikh, Salem Almaani, Sergey V. Brodsky, Brad H. Rovin - American Journal of Kidney Diseases 2020 cited by 489
- Update on Lupus Nephritis
Authors: Salem Almaani, Alexa Meara, Brad H. Rovin - Clinical Journal of the American Society of Nephrology 2016 cited by 918
- Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
Authors: Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, Jonathan Barratt, Stewart Bieler, Ulysses Diva, Jula K. Inrig, Radko Komers, Alex Mercer, Irene L. Noronha, Michelle N. Rheault, William E. Rote, Brad H. Rovin, Howard Trachtman, Hernán Trimarchi, Muh Geot Wong, Vlado Perkovic, Eric Alarmartine, Jonathan Barratt, Dong‐Wan Chae, Lucia Del Vecchio, Jürgen Floege, Shang‐Jyh Hwang, Bojan Jelaković, Bart Maes, Robert Małecki, Marius Miglinas, Fernando Nolasco, M Praga, Kannaiyan S Rabindranath, Mai Rosenberg, Brad H. Rovin, Sydney Tang, Vladmir Tesar, Muh Geot Wong, Bhadran Bose, Muralikrishna Gangadharan, Stephen P. McDonald, Chen Au Peh, Sadia Jahan, Chii Yeap, Philip A. Clayton, Georgina Irish, Nikhil Thyagarajan, Peter Hollett, Rathika Krishnasamy, Robert J. Carroll, Shilpanjali Jesudason, Susan Crail, Toby Coates, Jane Waugh, Euan Noble, Kumaradevan Mahadevan, Victoria Campbell, Tania Salehi, Wai H. Lim, Neil Boudville, Aron Chakera, Doris Chan, Anoushka Krishnan, Yusuf Eqbal, Alastair Gillies, Eswari Vilayur, Thida Maung Myint, Nicholas A. Gray, Jane Waugh, Euan Noble, Melissa S Cheetham, Yusuf Eqbal, Peter Hollett, Rathika Krishnasamy, Kumaradevan Mahadevan, Victoria Campbell, Carol A. Pollock, Bruce A. Cooper, Amanda Mather, Sarah Roxburgh, Yvonne Shen, Stefanie Stangenberg, Amanda Siriwardana, Emma O’Lone, Susan Wan, Brendon L. Neuen, Jeffrey T. Ha, Dana Kim, Lauren Heath, Arunima Jain, Elaine Phua, Li Yan, M. W. Gallagher, Meg Jardine, Angus Ritchie, Mona Razavian, Celine Foote, Roger Wyndham, Shaundeep Sen, Zoltán Endre, Jonathan Erlich, Mangalee Fernando, Kenneth Yong and 631 more - The Lancet 2023 cited by 215
- Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
Authors: Aliza Thompson, Kevin Carroll, Lesley A. Inker, Jürgen Floege, Vlado Perkovic, Sonia Boyer‐Suavet, Rupert Major, Judith Schimpf, Jonathan Barratt, Daniel C. Cattran, Barbara S. Gillespie, Annamaria Kausz, Alex Mercer, Heather N. Reich, Brad H. Rovin, Melissa West, Patrick H. Nachman - Clinical Journal of the American Society of Nephrology 2019 cited by 288
- Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Authors: Jonathan Barratt, Richard Lafayette, Jens Kristensen, Andrew Stone, Daniel Cattran, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Brad H. Rovin, Guillermo Fragale, Alejandra Karl, Patricia Losisolo, Hernán Trimarchi, Ivan Gonzalez Hoyos, Mauro Lampo, Matías Monkowski, Jorge de la Fuente, Magdalena Alvarez, Daniela Stoppa, Carlos Chiurchiu, P. Novoa, Marcelo Orías, Maria Belen Barron, Ana Paula Giotto, M. Arriola, Evelin Cassini, Rafaël Maldonado, Maria Paula Dionisi, Jessica Ryan, Nigel D. Toussaint, Grant Luxton, Chen Au Peh, Vicki Levidiotis, Ross S. Francis, Richard Phoon, Elena Fedosiuk, D.M. Toropilov Toropilov, R. E. Yakubtsevich, Elena Mikhailova, Christophe Bovy, Nathalie Demoulin, Jean‐Michel Hougardy, Bart Maes, Marijn M. Speeckaert, Louis‐Philippe Laurin, Sean Barbour, Mélanie Masse, Michelle Hladunewich, Heather N. Reich, Serge Cournoyer, Karthik Tennankore, Sean Barbour, Jicheng Lv, Zhangsuo Liu, Caili Wang, Shaomei Li, Qun Luo, Zhaohui Ni, Tiekun Yan, Ping Fu, Hong Cheng, Bi‐Cheng Liu, Wanhong Lu, Jianqin Wang, Qinkai Chen, D. Wang, Zuying Xiong, Menghua Chen, Yan Xu, Jiali Wei, Pearl Pai, Lianhua Chen, Jitka Řehořová, Dita Maixnerová, Roman Šafránek, Ivan Rychlík, M Hrubý, Satu Mäkelä, Kati Vääräniemi, Fernanda Ortiz, É. Alamartine, Maïté Daroux, C. Cartery, François Vrtovsnik, Jean‐Emmanuel Serre, Eleni Stamellou, Volker Vielhauer, Christian Hugo, Klemens Budde, Britta Otte, Martin Nitschke, Evangelia Ntounousi, Ioannis Boletis, Αikaterini Papagianni, Dimitrios Goumenos, Kostas Stylianou, Synodi Zermpala and 59 more - Kidney International 2022 cited by 215
- Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
Authors: David Jayne, Brad H. Rovin, Eduardo Mysler, Richard Furie, Frédéric Houssiau, Teodora Trasieva, J. Knagenhjelm, Erik Schwetje, Yen Lin Chia, Raj Tummala, Catharina Lindholm - Annals of the Rheumatic Diseases 2022 cited by 194
- A reference tissue atlas for the human kidney
Authors: Jens Hansen, Rachel Sealfon, Rajasree Menon, Michael T. Eadon, Blue B. Lake, Becky Steck, Kavya Anjani, Samir V. Parikh, Tara K. Sigdel, Guanshi Zhang, Dušan Veličković, Daria Barwinska, Theodore Alexandrov, Deján Dobi, Priyanka Rashmi, Edgar A. Otto, Miguel Rivera, Michael Rose, Christopher Anderton, John P. Shapiro, Annapurna Pamreddy, Seth Winfree, Yuguang Xiong, Yongqun He, Ian H. de Boer, Jeffrey B. Hodgin, Laura Barisoni, Abhijit S. Naik, Kumar Sharma, Minnie Sarwal, Kun Zhang, Jonathan Himmelfarb, Brad H. Rovin, Tarek M. El‐Achkar, Zoltán Lászik, John Cijiang He, Pierre C. Dagher, M. Todd Valerius, Sanjay Jain, Lisa M. Satlin, Olga G. Troyanskaya, Matthias Kretzler, Ravi Iyengar, Evren U. Azeloglu, Kidney Precision Medicine Project - Science Advances 2022 cited by 172
- Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
Authors: Hong Zhang, Dana V. Rizk, Vlado Perkovic, Bart Maes, Naoki Kashihara, Brad H. Rovin, Hernán Trimarchi, Ben Sprangers, Matthias Meier, Dmitrij Kollins, Olympia Papachristofi, Julie Milojevic, G. Junge, Prasanna Kumar Nidamarthy, Alan Charney, Jonathan Barratt - Kidney International 2023 cited by 121
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
Authors: Richard Lafayette, Pietro A. Canetta, Brad H. Rovin, Gerald B. Appel, Jan Novák, Karl A. Nath, Sanjeev Sethi, James A. Tumlin, Kshama Mehta, Marie C. Hogan, Stephen W. Erickson, Bruce A. Julian, Nelson Leung, Felicity Enders, Rhubell Brown, Barbora Knoppová, Stacy Hall, Fernando C. Fervenza - Journal of the American Society of Nephrology 2016 cited by 288
- A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis
Authors: Brad H. Rovin, Richard Furie, Y K Onno Teng, Gabriel Contreras, Ana Malvar, Xueqing Yu, Beulah Ji, Yulia Green, Tania Gonzalez‐Rivera, Damon Bass, Jennifer Gilbride, Chun‐Hang Tang, David A. Roth - Kidney International 2021 cited by 198
- Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
Authors: Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt, Stewart Bieler, Pietro A. Canetta, Dong‐Wan Chae, Gaia Coppock, Ulysses Diva, Loreto Gesualdo, Hiddo J.L. Heerspink, Jula K. Inrig, Gianna Mastroianni Kirsztajn, Donald E. Kohan, Radko Komers, Laura Kooienga, Kenneth V. Lieberman, Alex Mercer, Irene L. Noronha, Vlado Perkovic, Jai Radhakrishnan, William E. Rote, Brad H. Rovin, Vladimı́r Tesař, Hernán Trimarchi, James A. Tumlin, Muh Geot Wong, Howard Trachtman - New England Journal of Medicine 2023 cited by 105
